X-linked dominant hypophosphatemic rickets
MONDO:0010619X-linked hypophosphatemia (XLH) is a hereditary renal phosphate-wasting disorder characterized by hypophosphatemia, rickets and/or osteomalacia, and diminished growth.
Also known as: X-linked hypophosphatemia, X-linked hypophosphatemic rickets, X-linked dominant hypophosphatemic rickets, X-linked hereditary hypophosphatemic rickets, XLH, hereditary hypophosphatemic rickets, X-linked, hypophosphatemic rickets, X-linked, hypophosphatemic rickets, X-linked dominant, X-linked dominant
10 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
XLH study: watching the disease, not curing it
Knowledge-focused OngoingThis observational study follows 782 people with X-linked hypophosphatemia (XLH), a rare genetic bone disease, to understand how the condition changes over time. It also monitors the long-term safety and effectiveness of the drug burosumab. No new treatment is given; participants…
Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
XLH patients observed for a decade to uncover disease secrets
Knowledge-focused OngoingThis study follows 226 people with X-linked hypophosphatemia (XLH) for up to 10 years. Researchers will collect data on height, walking ability, fractures, and overall health to better understand how the disease progresses and affects daily life. No new treatment is being tested;…
Sponsor: Kyowa Kirin Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:22 UTC